BRIEF-Opiant Pharmaceuticals reports Q4 loss per share $0.17 By: Reuters: Company News October 13, 2017 at 07:36 AM EDT * Opiant Pharmaceuticals Inc reports fiscal fourth quarter and full year 2017 financial results and provides corporate update Read More >> Related Stocks: Opiant Pharmaceuticals Inc